+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Oral Cancer Treatment Market Research Report by Product Type, Treatment, Application, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4968733
  • Report
  • October 2021
  • Region: Global
  • 190 pages
  • 360iResearch™
UP TO OFF
until Jan 01st 2022
Global Oral Cancer Treatment Market is Projected to Reach USD 16.14 Billion by 2026, Registering a CAGR of 7.66%

FEATURED COMPANIES

  • Eli Lilly and Company
  • F. Hoffmann-La-Roche Ltd.
  • Merck & Co. Inc.
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • MORE
The Global Oral Cancer Treatment Market size was estimated at USD 10.36 billion in 2020, is expected to reach USD 11.12 billion in 2021, and projected to grow at a CAGR of 7.66% reaching USD 16.14 billion by 2026.



Market Statistics


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage


This research report categorizes the Oral Cancer Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Product Type, the market was studied across Lymphomas, Minor Salivary Gland Carcinomas, Squamous Cell Carcinoma, and Verrucous Carcinoma.
  • Based on Treatment, the market was studied across Chemotherapy, Radiation Therapy, Surgery, and Targeted Therapy.
  • Based on Application, the market was studied across Academic Institutes, Hospitals and Clinics, and Research Organization.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The analyst's ongoing research amplifies their research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Oral Cancer Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Oral Cancer Treatment Market, including Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La-Roche Ltd., Merck & Co., Inc., Mylan N.V., Novartis AG, Pfizer Inc., Qilu Pharmaceutical Co. Ltd., Sanofi S.A., and Teva Pharmaceutical Industries Ltd.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Oral Cancer Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Oral Cancer Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Oral Cancer Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Oral Cancer Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Oral Cancer Treatment Market?
6. What is the market share of the leading vendors in the Global Oral Cancer Treatment Market?
7. What modes and strategic moves are considered suitable for entering the Global Oral Cancer Treatment Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Eli Lilly and Company
  • F. Hoffmann-La-Roche Ltd.
  • Merck & Co. Inc.
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Increase in prevalence rate of oral cancers
5.2.2. Increasing unhealthy habits such as tobacco consumption and smoking
5.2.3. Increasing strategic acquisitions & collaborations for novel treatments
5.3. Restraints
5.3.1. Ignoring early symptoms of oral cancer
5.4. Opportunities
5.4.1. Rising demand for minimally invasive procedures
5.4.2. Recent advances in oral oncology screening
5.5. Challenges
5.5.1. Limited awareness about the disease in developing countries

6. Oral Cancer Treatment Market, by Product Type
6.1. Introduction
6.2. Lymphomas
6.3. Minor Salivary Gland Carcinomas
6.4. Squamous Cell Carcinoma
6.5. Verrucous Carcinoma

7. Oral Cancer Treatment Market, by Treatment
7.1. Introduction
7.2. Chemotherapy
7.3. Radiation Therapy
7.4. Surgery
7.5. Targeted Therapy

8. Oral Cancer Treatment Market, by Application
8.1. Introduction
8.2. Academic Institutes
8.3. Hospitals and Clinics
8.4. Research Organization

9. Americas Oral Cancer Treatment Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Oral Cancer Treatment Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand

11. Europe, Middle East & Africa Oral Cancer Treatment Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, by Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Bristol-Myers Squibb Company
13.2. Eli Lilly and Company
13.3. F. Hoffmann-La-Roche Ltd.
13.4. Merck & Co., Inc.
13.5. Mylan N.V.
13.6. Novartis AG
13.7. Pfizer Inc.
13.8. Qilu Pharmaceutical Co. Ltd.
13.9. Sanofi S.A.
13.10. Teva Pharmaceutical Industries Ltd.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
Figure 1. Global Oral Cancer Treatment Market Size, 2020 vs 2026 (USD Billion)
Figure 2. Global Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 3. Global Oral Cancer Treatment Market: Market Dynamics
Figure 4. Global Oral Cancer Treatment Market Size, by Product Type, 2020 vs 2026 (%)
Figure 5. Global Oral Cancer Treatment Market Size, by Product Type, 2020 vs 2026 (USD Billion)
Figure 6. Competitive Strategic Window for Global Oral Cancer Treatment Market Size, by Product Type, 2026
Figure 7. Global Oral Cancer Treatment Market Size, by Lymphomas, 2018-2026 (USD Billion)
Figure 8. Global Oral Cancer Treatment Market Size, by Lymphomas, by Region, 2020 vs 2026 (USD Billion)
Figure 9. Global Oral Cancer Treatment Market Size, by Minor Salivary Gland Carcinomas, 2018-2026 (USD Billion)
Figure 10. Global Oral Cancer Treatment Market Size, by Minor Salivary Gland Carcinomas, by Region, 2020 vs 2026 (USD Billion)
Figure 11. Global Oral Cancer Treatment Market Size, by Squamous Cell Carcinoma, 2018-2026 (USD Billion)
Figure 12. Global Oral Cancer Treatment Market Size, by Squamous Cell Carcinoma, by Region, 2020 vs 2026 (USD Billion)
Figure 13. Global Oral Cancer Treatment Market Size, by Verrucous Carcinoma, 2018-2026 (USD Billion)
Figure 14. Global Oral Cancer Treatment Market Size, by Verrucous Carcinoma, by Region, 2020 vs 2026 (USD Billion)
Figure 15. Global Oral Cancer Treatment Market Size, by Treatment, 2020 vs 2026 (%)
Figure 16. Global Oral Cancer Treatment Market Size, by Treatment, 2020 vs 2026 (USD Billion)
Figure 17. Competitive Strategic Window for Global Oral Cancer Treatment Market Size, by Treatment, 2026
Figure 18. Global Oral Cancer Treatment Market Size, by Chemotherapy, 2018-2026 (USD Billion)
Figure 19. Global Oral Cancer Treatment Market Size, by Chemotherapy, by Region, 2020 vs 2026 (USD Billion)
Figure 20. Global Oral Cancer Treatment Market Size, by Radiation Therapy, 2018-2026 (USD Billion)
Figure 21. Global Oral Cancer Treatment Market Size, by Radiation Therapy, by Region, 2020 vs 2026 (USD Billion)
Figure 22. Global Oral Cancer Treatment Market Size, by Surgery, 2018-2026 (USD Billion)
Figure 23. Global Oral Cancer Treatment Market Size, by Surgery, by Region, 2020 vs 2026 (USD Billion)
Figure 24. Global Oral Cancer Treatment Market Size, by Targeted Therapy, 2018-2026 (USD Billion)
Figure 25. Global Oral Cancer Treatment Market Size, by Targeted Therapy, by Region, 2020 vs 2026 (USD Billion)
Figure 26. Global Oral Cancer Treatment Market Size, by Application, 2020 vs 2026 (%)
Figure 27. Global Oral Cancer Treatment Market Size, by Application, 2020 vs 2026 (USD Billion)
Figure 28. Competitive Strategic Window for Global Oral Cancer Treatment Market Size, by Application, 2026
Figure 29. Global Oral Cancer Treatment Market Size, by Academic Institutes, 2018-2026 (USD Billion)
Figure 30. Global Oral Cancer Treatment Market Size, by Academic Institutes, by Region, 2020 vs 2026 (USD Billion)
Figure 31. Global Oral Cancer Treatment Market Size, by Hospitals and Clinics, 2018-2026 (USD Billion)
Figure 32. Global Oral Cancer Treatment Market Size, by Hospitals and Clinics, by Region, 2020 vs 2026 (USD Billion)
Figure 33. Global Oral Cancer Treatment Market Size, by Research Organization, 2018-2026 (USD Billion)
Figure 34. Global Oral Cancer Treatment Market Size, by Research Organization, by Region, 2020 vs 2026 (USD Billion)
Figure 35. Americas Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 36. Argentina Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 37. Brazil Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 38. Canada Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 39. Mexico Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 40. United States Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 41. Asia-Pacific Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 42. Australia Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 43. China Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 44. India Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 45. Indonesia Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 46. Japan Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 47. Malaysia Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 48. Philippines Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 49. Singapore Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 50. South Korea Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 51. Taiwan Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 52. Thailand Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 53. Europe, Middle East & Africa Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 54. France Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 55. Germany Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 56. Italy Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 57. Netherlands Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 58. Qatar Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 59. Russia Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 60. Saudi Arabia Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 61. South Africa Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 62. Spain Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 63. United Arab Emirates Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 64. United Kingdom Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Figure 65. Global Oral Cancer Treatment Market: FPNV Positioning Matrix
Figure 66. Global Oral Cancer Treatment Market: Share, by Key Player, 2020
Figure 67. Competitive Scenario Analysis in Global Oral Cancer Treatment Market, by Type

List of Tables
Table 1. Global Oral Cancer Treatment Market: Market Segmentation & Coverage
Table 2. United States Dollar Exchange Rate, 2016–2020
Table 3. Global Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 4. Global Oral Cancer Treatment Market Size, by Product Type, 2018-2026 (USD Billion)
Table 5. Global Oral Cancer Treatment Market Size, by Lymphomas, by Region, 2018-2026 (USD Billion)
Table 6. Global Oral Cancer Treatment Market Size, by Minor Salivary Gland Carcinomas, by Region, 2018-2026 (USD Billion)
Table 7. Global Oral Cancer Treatment Market Size, by Squamous Cell Carcinoma, by Region, 2018-2026 (USD Billion)
Table 8. Global Oral Cancer Treatment Market Size, by Verrucous Carcinoma, by Region, 2018-2026 (USD Billion)
Table 9. Global Oral Cancer Treatment Market Size, by Treatment, 2018-2026 (USD Billion)
Table 10. Global Oral Cancer Treatment Market Size, by Chemotherapy, by Region, 2018-2026 (USD Billion)
Table 11. Global Oral Cancer Treatment Market Size, by Radiation Therapy, by Region, 2018-2026 (USD Billion)
Table 12. Global Oral Cancer Treatment Market Size, by Surgery, by Region, 2018-2026 (USD Billion)
Table 13. Global Oral Cancer Treatment Market Size, by Targeted Therapy, by Region, 2018-2026 (USD Billion)
Table 14. Global Oral Cancer Treatment Market Size, by Application, 2018-2026 (USD Billion)
Table 15. Global Oral Cancer Treatment Market Size, by Academic Institutes, by Region, 2018-2026 (USD Billion)
Table 16. Global Oral Cancer Treatment Market Size, by Hospitals and Clinics, by Region, 2018-2026 (USD Billion)
Table 17. Global Oral Cancer Treatment Market Size, by Research Organization, by Region, 2018-2026 (USD Billion)
Table 18. Americas Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 19. Argentina Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 20. Brazil Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 21. Canada Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 22. Mexico Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 23. United States Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 24. Asia-Pacific Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 25. Australia Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 26. China Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 27. India Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 28. Indonesia Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 29. Japan Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 30. Malaysia Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 31. Philippines Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 32. Singapore Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 33. South Korea Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 34. Taiwan Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 35. Thailand Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 36. Europe, Middle East & Africa Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 37. France Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 38. Germany Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 39. Italy Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 40. Netherlands Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 41. Qatar Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 42. Russia Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 43. Saudi Arabia Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 44. South Africa Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 45. Spain Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 46. United Arab Emirates Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 47. United Kingdom Oral Cancer Treatment Market Size, 2018-2026 (USD Billion)
Table 48. Global Oral Cancer Treatment Market: Scores
Table 49. Global Oral Cancer Treatment Market: Business Strategy
Table 50. Global Oral Cancer Treatment Market: Product Satisfaction
Table 51. Global Oral Cancer Treatment Market: Ranking
Table 52. Global Oral Cancer Treatment Market: Share, by Key Player, 2020
Table 53. Global Oral Cancer Treatment Market: Merger & Acquisition
Table 54. Global Oral Cancer Treatment Market: Agreement, Collaboration & Partnership
Table 55. Global Oral Cancer Treatment Market: New Product Launch & Enhancement
Table 56. Global Oral Cancer Treatment Market: Investment & Funding
Table 57. Global Oral Cancer Treatment Market: Award, Recognition & Expansion
Table 58. Global Oral Cancer Treatment Market: License & Pricing
Note: Product cover images may vary from those shown
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • F. Hoffmann-La-Roche Ltd.
  • Merck & Co. Inc.
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • Qilu Pharmaceutical Co. Ltd.
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll